Fight against COVID-19: Third phase of human trial of Covaxin to commence soon in IMS- SUM Hospital
Bhubaneswar/UNI: The third phase of the human trial of COVAXIN, the much-awaited indigenous vaccine being developed against Covid-19, will commence at the Institute of Medical Sciences and SUM Hospital here soon.
Pune: Adar Poonawalla, chief executive of the Serum Institute of India, has said it will take four to five years until everyone gets the COVID-19 vaccine on this planet.
DCGI approves Phase II+III trials of Oxford University vaccine by Serum Institute
New Delhi: The Drugs Controller General of India (DCGI) has given approval to Serum Institute of India, Pune to conduct Phase II+III clinical trials of Oxford University-Astra Zeneca COVID-19 vaccine (COVISHIELD) in India. This will hasten the development of the COVID-19 vaccine.